Table 4. Laboratory methods for Cushing’s syndrome diagnosis.
Method | Reference value | Sensitivity % | Specificity % |
---|---|---|---|
First-line methods | |||
Low-dose dexamethasone suppression test - 1 mg overnight (serum cortisol) (27) | > 1.8 µg/dL | > 95 | 80 |
Longer low-dose dexamethasone suppression test - 2 mg/day for 48 h – 0.5 mg 6/6 h (serum cortisol) (68)* | > 1.8 µg/dL | 92-100 | 92-100 |
Late night salivary cortisol (µg/dL or ng/dL or mmol/L) (56) | > 2X ULNR | 88-100 | 82-100 |
Urinary free cortisol 24 h (µg/24 h) (68) | > 3-4X ULNR | 90-98 | 45-95 |
Other methods (second-line) | |||
Late-night serum cortisol (patient awake) (78) | > 7.5 µg/dL | 96 | 100 |
Ovine CRH after longer low-dose dexamethasone suppression test (serum cortisol) (81-84) | > 1.4 µg/dL (15’) | < 100 | < 100 |
Human CRH test (plasma ACTH, pg/mL; serum cortisol, µg/dL) (86) | Peak > 54 pg/mL and > 12 µg/dL (baseline) | 91.3 | 98.2 |
Desmopressin test (plasma ACTH, pg/mL; serum cortisol, µg/dL) (90) | ∆ > 18 pg/mL and > 12 µg/dL (baseline) | 86.6-100 | 92.8 |
∆: delta: peak less baseline value; ULNR: upper limit of normal range; * Meta-analysis showed a similar or lower accuracy than that of the low-dose dexamethasone suppression test (1 mg overnight) (54); serum cortisol: μg/dL; to nmol/L, multiply by 27.59; ACTH: pg/mL; to pmol/L, multiply by 0.2202; urinary cortisol: μg/24 h; to nmol/24 h, multiply by 2.759.